Net Cash Provided by (Used in) Financing Activities in USD of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Pacific Biosciences Of California, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Pacific Biosciences Of California, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $1.96M, a 70.1% decline year-over-year.
  • Pacific Biosciences Of California, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$43M, a 139% decline from 2023.
  • Pacific Biosciences Of California, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $109M, a 1032% increase from 2022.
  • Pacific Biosciences Of California, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $9.62M, a 99.2% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $1.96M -$4.59M -70.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q1 2024 $6.55M -$189M -96.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q1 2023 $196M +$191M +3658% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $5.22M -$861M -99.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $866M +$848M +4657% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 $18.2M +$11.5M +172% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $6.69M -$28.8M -81.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $35.5M +$32.1M +941% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q1 2017 $3.41M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q1 2014 $23M -$6.7M -22.6% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-08
Q1 2013 $29.7M +$27.9M +1590% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 $1.76M +$1.42M +427% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 $333K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$43M -$152M -139% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 $109M +$99.3M +1032% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 $9.62M -$1.16B -99.2% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-17
2021 $1.17B +$918M +364% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $252M +$225M +849% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $26.5M -$80.6M -75.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $107M +$38.4M +55.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $68.8M +$2.88M +4.37% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $65.9M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2013 $42.8M +$40.1M +1481% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-14
2012 $2.71M -$5.04M -65.1% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-14
2011 $7.74M -$311M -97.6% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 $319M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.